1-(1-(4-chlorobenzyl)-1H-indole-2-carbonyl)-N-((2,3-dihydro-1H-inden-2-yl)methyl)piperidine-4-carboxamide

ID: ALA4870800

PubChem CID: 56927671

Max Phase: Preclinical

Molecular Formula: C32H32ClN3O2

Molecular Weight: 526.08

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCC1Cc2ccccc2C1)C1CCN(C(=O)c2cc3ccccc3n2Cc2ccc(Cl)cc2)CC1

Standard InChI:  InChI=1S/C32H32ClN3O2/c33-28-11-9-22(10-12-28)21-36-29-8-4-3-7-27(29)19-30(36)32(38)35-15-13-24(14-16-35)31(37)34-20-23-17-25-5-1-2-6-26(25)18-23/h1-12,19,23-24H,13-18,20-21H2,(H,34,37)

Standard InChI Key:  RHFQVABRYBELDJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   12.7517  -28.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7506  -28.8805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4586  -29.2895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1683  -28.8801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1655  -28.0574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4568  -27.6521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8766  -29.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8779  -30.1047    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2921  -31.3600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5432  -30.5824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4748  -31.3613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2233  -30.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4290  -30.4198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8854  -31.0249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1417  -31.8005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9354  -31.9645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0439  -27.6526    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   16.3195  -30.3271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4865  -29.5271    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9288  -30.8716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.7574  -31.6670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3627  -32.2107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1406  -31.9592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3097  -31.1588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7009  -30.6097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7478  -32.5061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5779  -33.3054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.5251  -32.2537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1323  -32.8006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9095  -32.5481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5702  -33.0272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1618  -31.7697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9789  -31.7696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2304  -32.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0267  -32.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5723  -32.1084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3161  -31.3305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5204  -31.1653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8 12  1  0
 11  9  1  0
  9 10  2  0
 10  8  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  1 17  1  0
 10 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 34  1  0
 33 32  1  0
 32 30  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 33  1  0
M  END

Associated Targets(non-human)

Western equine encephalitis virus (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 526.08Molecular Weight (Monoisotopic): 525.2183AlogP: 5.73#Rotatable Bonds: 6
Polar Surface Area: 54.34Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 5.76CX LogD: 5.76
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.35Np Likeness Score: -1.35

References

1. Barraza SJ, Sindac JA, Dobry CJ, Delekta PC, Lee PH, Miller DJ, Larsen SD..  (2021)  Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore.,  46  [PMID:34098081] [10.1016/j.bmcl.2021.128171]

Source